Details include: the prevalence and incidence of atopic dermatitis; its aetiology; triggers; the skin barrier dysfunction that underlies the disease; the role of the immune system; symptoms and comorbidities; the personal,
familial and financial burden; measuring disease severity; the role of cytokines; the use of antihistamines, calcineurin inhibitors and interleukin inhibitors to relieve the itch; and information on topical corticosteroid and calcineurin inhibitors, systemic therapies and future treatments.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
This content has been developed independently of the sponsors who have had no editorial input into the content. Medthority received educational funding from the sponsor Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.